文献速递肿瘤 PET/CT核素与放射性配体治疗

靶向检测肾上腺皮质癌复发与转移:99mTc-FAPI-46 SPECT/CT 成像新方法

Targeted Detection of Recurrence and Metastasis in Adrenocortical Carcinoma: A Novel Approach Using 99mTc-FAPI-46 SPECT/CT Imaging.
PubMed 文献 · Clin Nucl Med · 2025-06-04

本文报告一例73岁男性肾上腺皮质癌患者,既往因复发和转移病灶接受多次手术和治疗。患者接受99mTc-FAPI-46扫描,所有对比增强CT及后续剖腹术发现的肿瘤病灶均显示FAPI摄取,靶本比良好。作者经验提示,99mTc-FAPI-46 SPECT/CT或可作为肾上腺皮质癌的有价值补充诊断手段,尤其在PET/CT不可及时。

要点

  • 73岁男性肾上腺皮质癌患者,既往多次手术及治疗复发转移灶。
  • 99mTc-FAPI-46 SPECT/CT显示所有CT及剖腹术发现的肿瘤病灶均有FAPI摄取,靶本比良好。
  • 作者认为99mTc-FAPI-46 SPECT/CT或可作为肾上腺皮质癌的补充诊断手段,尤其在PET/CT不可及时。

核心结论

  • 作者经验提示,99mTc-FAPI-46 SPECT/CT或可作为肾上腺皮质癌的有价值补充诊断手段,尤其在PET/CT不可及时。

研究设计与样本

  • 本文报告一例73岁男性肾上腺皮质癌病例,该患者有多次手术及治疗复发和转移病灶的病史。

主要发现

  • 99mTc-FAPI-46扫描显示,对比增强CT及后续剖腹术发现的所有肿瘤病灶均有FAPI摄取,靶本比良好。

临床怎么用

  • 作者认为,鉴于FAPI类显像剂的潜力,在肾上腺皮质癌管理中应重视全面评估并考虑其他诊断手段。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We present a case of a 73-year-old man with a history of adrenocortical carcinoma (ACC) who underwent multiple surgeries and treatments for recurrent and metastatic lesions. The patient underwent a 99mTc-FAPI-46 scan, which revealed FAPI uptake in all tumoral masses detected on contrast-enhanced CT scans and subsequent laparotomy, with favorable target-to-background ratios. Our experience suggests that 99mTc-FAPI-46 SPECT/CT may be a valuable complementary diagnostic modality for ACC, especially when PET/CT is not available. This case highlights the importance of comprehensive evaluation and consideration of other diagnostic modalities in the management of ACC, given the potential of FAPI-based imaging agents.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Raeisi N, Saber Tanha A, Soltani E, et al. Targeted Detection of Recurrence and Metastasis in Adrenocortical Carcinoma: A Novel Approach Using 99mTc-FAPI-46 SPECT/CT Imaging. Clin Nucl Med. 2025. PMID: 40462327. doi:10.1097/RLU.0000000000005734

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。